In conclusion, identification of the IKK complex as a coordination point in convergence of PI3K-Akt and NF-κB pathways in prostate cancer will serve as a guide for selection of biological experiments for the discovery of molecular drug targets. The gene discussed is AKT1; the disease is prostate cancer.